Khus (Vetiveria zizanioides)

Vetiver (Vetiveria zizanioides) is an aromatic grass containing vetivone and vetiselinenol that modulates GABA neurotransmission and inflammatory pathways. Animal studies suggest potential anxiolytic and anticonvulsant properties through GABAergic enhancement and oxidative stress reduction.

Origin & History

Khus (Vetiveria zizanioides) is a perennial grass native to India with an extensive root system from which essential oil is extracted via steam distillation. The resulting amber-colored oil is rich in sesquiterpenes and has been traditionally used in tropical regions for over 2,000 years.

Historical & Cultural Context

In Ayurveda and Siddha medicine systems, khus roots have been used for over 2,000 years for inflammation, pain, infections, fever reduction, anxiety, and metabolic disorders. Traditional preparations include decoctions, pastes, and oils for both topical and oral applications.

Health Benefits

• May reduce seizure activity and oxidative stress in epilepsy models (preliminary animal evidence, 200-400 mg/kg reduced seizure duration in rats)
• Demonstrates anxiolytic effects in preclinical studies (preliminary evidence, 100-300 mg/kg showed activity in mouse anxiety tests)
• Shows anti-inflammatory activity through reduction of TNF-α (≥23%) and IL-1β (up to 81%) (in vitro evidence only)
• May support memory and cognitive function by antagonizing scopolamine-induced deficits (preliminary mouse model evidence)
• Exhibits antioxidant properties through free radical scavenging mechanisms (in vitro evidence)

How It Works

Vetiver's bioactive compounds vetivone and vetiselinenol appear to enhance GABAergic neurotransmission, potentially through positive allosteric modulation of GABA-A receptors. The herb also demonstrates anti-inflammatory activity by inhibiting pro-inflammatory cytokines and reducing lipid peroxidation markers. These dual mechanisms may contribute to its observed neuroprotective and anxiolytic effects in preclinical models.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on khus. Research is limited to preclinical studies including a rat epilepsy model (PMID: 39576294) showing reduced seizure duration with 200-400 mg/kg vetiver oil, and mouse studies demonstrating anxiolytic and nootropic effects at 100-300 mg/kg ethanolic root extract.

Clinical Summary

Current evidence for vetiver is limited to animal and in vitro studies, with no published human clinical trials. Rat studies using 200-400 mg/kg doses showed reduced seizure duration and oxidative stress markers in epilepsy models. Mouse anxiety studies demonstrated anxiolytic activity at 100-300 mg/kg doses in elevated plus maze and open field tests. The preliminary nature of this evidence limits conclusions about human efficacy and optimal dosing.

Nutritional Profile

{"macronutrients": {"fiber": "Approximately 3-5% by weight", "protein": "Low, typically less than 1% by weight"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts"}, "minerals": {"Potassium": "Moderate levels, approximately 100-150 mg/100g", "Calcium": "Low levels, approximately 10-20 mg/100g"}}, "bioactive_compounds": {"Vetiverol": "Major component, approximately 50-60% of essential oil", "Khusimol": "Significant component, approximately 10-15% of essential oil", "Zizanoic acid": "Minor component, less than 5% of essential oil"}, "bioavailability_notes": "The bioavailability of vetiver's bioactive compounds can vary based on extraction method and preparation. Essential oils are typically used for therapeutic purposes, and their absorption can be enhanced through topical application or inhalation."}

Preparation & Dosage

No clinically studied human dosages exist. Animal studies used 100-300 mg/kg oral ethanolic root extract for cognitive effects and 200-400 mg/kg oral vetiver oil for epilepsy models. Human equivalent doses cannot be reliably extrapolated. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ashwagandha, Brahmi, Gotu Kola, Tulsi, Turmeric

Safety & Interactions

Safety data for vetiver supplementation in humans is extremely limited due to lack of clinical trials. Traditional use suggests generally good tolerance, but potential side effects, drug interactions, and contraindications remain poorly characterized. Pregnancy and breastfeeding safety is unknown and should be avoided. Individuals taking anticonvulsant medications or anxiolytics should consult healthcare providers before use due to potential additive effects on GABAergic pathways.